The trial looked at the safety and effectiveness of tirzepatide in two scenarios: Continuing to take tirzepatide at the maximum tolerated dose (10 or 15 milligrams [mg], depending on the patient) after initial treatment on that dose Lowering the dose to 5 mg after initial treatment to maintain weight loss
Monitoring liver enzymes ensures neither compound is causing hepatotoxicity
Clinical use and practical aspects Patients who need further intensification of therapy but have had it delayed because of concerns about potential weight gain and hypoglycemic episodes would probably benefit from fixed-ratio combination of basal insulin and GLP-1Ras [19, 22, 23, 25,26,27, 30, 31]
Participants underwent genotyping on an Illumina HumanCoreExome v.12.1 array
With four convenient Tampa Bay locations, youll receive hands-on support and expert guidance throughout your journey